We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : McKesson HBOC (MCK)
MCK 589.99+0.7%4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wally Mastroly who wrote (151)2/22/2000 10:40:00 AM
From: Mort  Read Replies (1) of 165
Somebody has faith in MCK

February 16, 2000 07:02 PM
WASHINGTON, Feb 16 (Reuters) - David Geffen, one of the three leaders at Hollywood film studio DreamWorks, said on Wednesday he acquired a stake currently worth more than $278 million in McKesson HBOC Inc.MCK , the largest U.S. drug distributor.

Geffen, who heads DreamWorks with Hollywood heavyweights Steven Spielberg and Jeffrey Katzenberg, acquired 5 percent, or 14,087,700 common shares, for general investment purposes, according to a filing with the U.S. Securities and Exchange Commission.

Using his personal funds, Geffen bought shares of San Francisco-based McKesson between Dec. 13 and Feb. 11 at prices ranging from $18.8750-$22.6250 a share.

The largest one-day purchase during that period were 1 million shares on Jan. 25 for $22.50 each, and an additional 1 million shares bought two days later at $20.9375 each.

Geffen disclosed his stake in the company because of SEC rules that say anyone holding a stake of 5 percent or more in a company must publicly report their holdings.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext